Elanco to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
Get Alerts ELAN Hot Sheet
Join SI Premium – FREE
GREENFIELD, Ind.--(BUSINESS WIRE)-- Elanco Animal Health Incorporated (NYSE: ELAN) will attend the Goldman Sachs 43rd Annual Global Healthcare Conference, June 13-14, 2022. Todd Young, executive vice president and CFO, will participate in a fireside chat on Monday, June 13 at 6:20 p.m. ET (3:20 p.m. PT).
A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days.
ABOUT ELANCO
Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220606005115/en/
Investor Contact: Katy Grissom (317) 273-9248 [email protected]
Media Contact: Colleen Parr Dekker (317) 989-7011 [email protected]
Source: Elanco Animal Health Incorporated
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goku Technologies Chooses SS&C for Fund Services
- Boomi Announces 2026 APAC Customer Innovation Award Winners
- Emburse Spend Expands Globally, Launching in Australia as Its First Market Outside the U.S.
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Goldman SachsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share